Buying or selling a cannabis business in Maryland

Legal status and regulator

Maryland licenses both medical and adult-use cannabis. Voters approved adult use in November 2022 and sales started on 1 July 2023, when existing medical licensees could convert to standard licenses covering both markets. The Maryland Cannabis Administration regulates the industry under the Alcoholic Beverages and Cannabis Article and COMAR Title 14, Subtitle 17.

License types and caps

Maryland is a capped market. The 2023 law authorises 75 standard grower, 100 standard processor, and 300 standard dispensary licenses, plus micro licenses in each class, 50 on-site consumption facilities, and 10 incubator spaces. Those numbers are set in statute, not by demand.

Limit	Rule
Standard licenses statewide	75 grower, 100 processor, 300 dispensary
Per owner	1 grower, 1 processor, 4 dispensaries, 2 incubator, 2 on-site consumption
Passive investor exemption	Under 5% in aggregate with no control does not count toward the cap
Dispensary spacing	1,000 feet apart, 500 feet from schools, playgrounds and childcare

The Administration ran social equity lotteries in March and June 2024, awarding 205 licenses across the micro and standard classes. Roll-out has been slow: as of mid-July 2026 only 17 of the 83 social equity dispensary licenses issued since 2023 were operating, about twice as many as at the start of the year. A further round authorised in 2025 is expected to add more standard grower, processor, and dispensary licenses.

Standard license fees run for five years: $50,000 for a grower, $25,000 for a processor or dispensary, and $10,000 for a micro license, on top of a $5,000 standard application fee, per COMAR 14.17.21.02. Social equity licensees pay half.

How does a sale work in Maryland?

The license stays with the entity and the Administration approves the people behind it. A transfer of less than 5% that leaves the transferee under 5% does not need review. At or above 5%, the Administration takes notice of the intent to transfer, checks that the transfer does not violate state law, collects criminal history and financial information, and charges the fee: $1,000 where the transferee is an entity and $500 per individual transferee. The general mechanics are in change of ownership approval explained.

The real constraint is timing, not paperwork. Two locks overlap.

1. The five-year statutory bar. Under Alcoholic Beverages and Cannabis Article 36-503, any cannabis licensee, social equity or not and including a converted licensee, may not transfer ownership or control for at least five years after licensure; time in preapproved status does not count. The exceptions are death, disability, or incapacity of the owner, bankruptcy, receivership under a lending agreement, court order, a sale to the licensee’s employees through an employee stock ownership plan, and settlements of litigation begun on or before 1 January 2023.
2. The converted-license bar. Administration guidance says a license converted from medical to adult use may not transfer a controlling interest, or control, before 1 July 2028. Those converted licenses are the state’s largest and most profitable operators.

Control is read broadly. Maryland counts veto rights over significant events, authority over capital allocation, power to appoint or remove officers, and authority to sign contracts of $10,000 or more in aggregate. An option or management agreement that hands those rights over early is a transfer of control, whatever the cap table says. Lawful deals today tend to be minority investments, financing, or purchase agreements with a regulatory-approval contingency closing after the bar lifts. Comparable rules are in the state license transfer rules overview.

Social equity transfer restrictions

Conditional licenses cannot be sold, gifted, or transferred at all. For the 2023 to 2024 round, 65% of equity must stay with verified social equity applicants and the individuals named on the application must keep at least 51%. Time spent in preapproved status does not count toward the five years. That leaves up to 35% available to outside capital, which is where most Maryland investment activity has gone. See selling a social equity license and social equity license transfer restrictions.

Residency and ownership limits

There is no general residency requirement. Social equity eligibility was tied to living or attending school in a disproportionately impacted area, and that programme survived a dormant Commerce Clause challenge in Jensen v. Maryland Cannabis Administration, which the Supreme Court declined to review on 23 February 2026. Ownership caps and the under-5% passive investor exemption are compared with other states in ownership caps and residency rules by state.

Local control

Counties and municipalities can zone but cannot ban. The 2023 law bars local requirements that are disproportionately more burdensome than those imposed on other businesses, and bars bans on transport and delivery. A 2024 law effective 1 June 2024 gave counties more flexibility, including power to widen the spacing between dispensaries beyond the state’s 1,000-foot rule. Local practice varies, and Baltimore is its own case.

Taxes, 280E and track-and-trace

Maryland taxes adult-use sales at 12%, raised from 9% on 1 July 2025. Medical sales are untaxed. Rates elsewhere are in cannabis excise and potency taxes by state.

The state decoupled from section 280E under Tax-General Article 10-208 for tax years beginning after 31 December 2021, so licensed growers, processors, and dispensaries deduct ordinary expenses on Maryland returns. Federal 280E still applies to adult-use income. See state 280E decoupling.

Maryland uses Metrc, so a buyer can test reported revenue against regulator data as described in verifying revenue with track-and-trace data.

Market conditions in 2026

Fiscal 2025, ending 30 June 2025, produced about $1.16 billion in combined sales, roughly $874 million adult-use and $289 million medical. Calendar 2025 came in at about $1.17 billion, per the Administration’s monthly market data.

2026 has grown modestly in dollars and faster in units. March 2026 sales crossed $100.9 million, taking the year to date to $292 million, about $82 million adult-use and $18 million medical. April was $100.8 million, up about 3.5% year over year, on 3.72 million units, up 7.6%. Price is doing the work: the average gram of flower fell to $7.84 from $8.72, and the average item to $26.59 from $28.14. Current figures sit on the Administration’s data dashboard.

What this means for sellers

Establish which clock you are on before you talk to anyone. A converted licensee selling control in 2026 has no lawful path except the narrow statutory exceptions, and buyers know it. What you can do is raise minority capital, sell a stake below the control line, or sign now to close after July 2028 with terms that leave real control with you until then. Social equity holders in their five-year window have the same shape of problem with a different end date. Falling prices mean a buyer will underwrite this year’s basket size, not 2023’s.

What this means for buyers

The license count overstates the buyable inventory. Count how many Maryland licenses are free to change control this year, then how many of those are open and generating revenue. Check the cap before you bid: four dispensaries is the ceiling, and any veto right or management fee you negotiate may count as control against it. Distress is the other route in, and the Administration charges a $1,000 receivership application fee; see cannabis receivership sales explained. No separate Maryland business broker license has been identified for a sale without real estate, though including the property brings in real estate licensing; see business broker licensing by state. Pricing logic for capped markets is in license value in capped vs uncapped states.

This page is general information, not legal or tax advice. To talk through a Maryland sale or acquisition in confidence, book an intro call.